Global Neuroendovascular Non-coils Market 2016-2020

Global Neuroendovascular Non-coils Market 2016-2020

About Neuroendovascular Non-coils

A neuroendovascular non-coil is used to treat an unruptured or ruptured brain aneurysm (a weakened area in the artery wall). The treatment is either known as endovascular coiling or endovascular embolization. During this procedure, the neuroendovascular non-coil blocks the blood flow in an aneurysm. The treatment is usually performed under general anesthesia by interventional neuroradiologists using fluoroscopic imaging guidance. Neuroendovascular non-coils are used as alternatives to coils in the treatment of an aneurysm.

Technavio’s analysts forecast the global neuroendovascular non-coils market to grow at a CAGR of 12.9% during the period 2016-2020.

Covered in this report

The report covers the present scenario and the growth prospects of the global neuroendovascular non-coils market for 2016-2020. To calculate the market size, the report considers the revenue generated from the sales of medical devices required for thoracic surgeries.The market is divided into the following segments based on geography:

• Americas
• APAC
• EMEA

Technavio's report, Global Neuroendovascular Non-coils Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors

• Boston Scientific
• Medtronic
• Sorin
• St. Jude Medical
• Terumo

Other prominent vendors

• Abiomed
• AdvanSource Biomaterials
• AGA Medical
• Allium Medical
• AngioDynamics
• Angioslide
• Atrium Medical
• Biophan Technologies
• Biosense Webster
• Cardiac Science
• CardiacAssist
• Dextera Surgical
• Cardio-Flow
• Claret Medical
• Contego Medical
• Cook Group
• Cryolife
• Innovative Cardiovascular Solutions
• Keystone Heart
• St. Jude Medical
• phenox
• InspireMD
• Acandis
• Transverse Medical

Market driver

• Rise in incidence of cardiac disorders and increase in aging population
• For a full, detailed list, view our report

Market challenge

• Potential complications associated with cardiac surgery
• For a full, detailed list, view our report

Market trend

• Growing popularity of robot-assisted cardiac surgery
• For a full, detailed list, view our report

Key questions answered in this report

• What will the market size be in 2020 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?

Press Release

Technavio Announces the Publication of its Research Report – Global Neuroendovascular Non-coils Market 2016-2020.

Technavio recognizes the following companies as the key players in the global neuroendovascular non-coils market: DePuy Synthes, Medtronic, MicroVention, and Stryker.

Other Prominent Vendors in the market are: Abiomed, AdvanSource Biomaterials, AGA Medical, Allium Medical, AngioDynamics, Angioslide, Atrium Medical, Biophan Technologies, Biosense Webster, Cardiac Science, CardiacAssist, Dextera Surgical, Cardio-Flow, Claret Medical, Contego Medical, Cook Group, Cryolife, Innovative Cardiovascular Solutions, Keystone Heart, St. Jude Medical, phenox, InspireMD, Acandis, and Transverse Medical.

Commenting on the report, an analyst from Technavio’s team said: “Flow diversion aneurysm stenting is likely to become one of the widely accepted minimally invasive (MI) procedures for the treatment of an intracranial aneurysm. Physicians' acceptance of flow diverters worldwide led to increased use of other endovascular stents. This shows that flow diversion aneurysm treatment is widely accepted among various medical professionals worldwide, with many hospitals and healthcare centers recommending the procedure to people with carotid artery stenosis.

According to the report, high incidence rates of brain aneurysm and cerebral disorders is one of the major drivers for this market. Brain aneurysm is a common neurological disorder which occurs in 2-6% individuals globally. Cerebral aneurysms are more common in women, and the prevalence of aneurysm increases if a first-degree of relative (i.e., parent, sibling, or child) has an aneurysm. Some of the major causes for cerebral aneurysms include, blood pressure, blood glucose, and lipids. These disorders occur due to unhealthy diet, less physical activity, excessive alcohol consumption, smoking, stress, and obesity and are very common in the age group of 40 years above.

Further, the report states that Currently, the volume of surgeries for the treatment of neuroendovascular diseases is growing at a significant rate owing to rising prevalence, but there is a dearth of skilled neurosurgeons and interventional radiologists with expertise in non-coil neuroendovascular devices. High technical expertise is required to use this equipment effectively to record data and diagnose brain injuries. Only professional surgeons and highly skilled technicians perform these procedures in hospitals, clinics, and trauma centers.



Companies Mentioned

DePuy Synthes, Medtronic, MicroVention, Stryker, Abiomed, AdvanSource Biomaterials, AGA Medical, Allium Medical, AngioDynamics, Angioslide, Atrium Medical, Biophan Technologies, Biosense Webster, Cardiac Science, CardiacAssist, Dextera Surgical, Cardio-Flow, Claret Medical, Contego Medical, Cook Group, Cryolife, Innovative Cardiovascular Solutions, Keystone Heart, St. Jude Medical, phenox, InspireMD, Acandis, Transverse Medical.